CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01970371
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:07.636719+00:00
Published At: 2018-10-16T00:00:00+00:00
Record Updated At: 2018-10-16
Results Posted At: 2018-10-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Bloodstream Infections (BSI) Due to CRE", "Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE", "Ventilator-Associated Bacterial Pneumonia (VABP) Due to CRE", "Complicated Urinary Tract Infection (cUTI) Due to CRE", "Acute Pyelonephritis (AP) Due to CRE"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-10-16"
protocolSection.identificationModule.nctId: "NCT01970371"
protocolSection.identificationModule.officialTitle: "A Phase 3, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-10-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.